This meeting will highlight novel laboratory approaches, innovative pre-clinical science and the latest clinical trial results. The aim is to discuss and advance understanding of the aetiology, diagnosis and treatment of this challenging disease. The meeting will be a three day programme covering all aspects of triple negative disease with invited plenary speakers and proffered abstracts presented as short talks or posters. We aim to create a workshop atmosphere with ample opportunity for discussion and sharing expertise across disciplines.